ARCHIVES

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

This article is from The Cancer Letter archive.

Vol. 36 No. 22 | June 11, 2010

Download PDF Visit The Full Archive

Related Articles

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

June 23, 1989

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

March 1, 1991